FDA Approves H5N1 Vaccine For Use In Epidemic

“The Food and Drug Administration [FDA] said Friday it has approved a vaccine made by GlaxoSmithKline Plc for use in the event of an H5N1 bird flu epidemic,” Al Jazeera America reports (11/24). “H5N1 made news around the globe last year when two groups of researchers published [papers] on mutations that could make the virus transmissible between ferrets, an oft-used model for the dynamics of human infections,” The Scientist notes, adding, “With an estimated 50 percent to 60 percent mortality rate in people, mutations that allowed the virus to pass from human to human could cause a massive epidemic” (Akst, 11/25).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.